|
|
 |
|
|
 |
|
|
| |
|
December 21, 2005 |
| |
|
Welcome to ACAAI eNews — a bi-weekly aggregated news service
from the American College of Allergy, Asthma & Immunology. To be
removed from this distribution list, please see instructions at
bottom. |
| |
 |
Top
Stories |
| |
|
 |
Drugs & Devices |
|
|
|
 |
Distance Learning |
|
|
|
 |
Association
News |
| |
|
 |
Fellows-in-Training |
| |
|
 |
Calendar |
| |
|
 |
Archive |
|
|
|
|
 |
FIT Archive |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Of these options, readers said the most appropriate source for
funding clinical allergy-immunology subspecialty training was:
|
55% |
Medical schools
and their associated hospitals |
|
41% |
Federal
government |
|
5% |
State government |
|
0% |
Managed care
organizations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Distance Learning |
2005 Board/Recertification Review Course:
DVDs, Audio CDs, MP3s
Link
ACAAI Tape Store
Complete Listing
Link
2004 ACAAI ANNUAL MEETING
Nov. 12-17, Boston
Link
From the 2003 ACAAI ANNUAL MEETING
Nov. 7-12, 2003, New Orleans
• Two Symposia Online
Link
• Plenary Sessions CD-ROM and DVD
Link
Patient-Centered Allergy Practice
Endorsed by ACAAI, Sponsored by Physicians Practice
Link
|
Calendar |
|
JANUARY
The Management of Pediatric
Allergy:
In Whose Hands? – from Bench to Bedside
In cooperation with ACAAI
Jan. 20-26, 2006
Milan, Italy
Tel: 39-02-34934404
Fax: 39-02-34934397
E-mail
Link
WSAAI 44th
Annual Scientific Session
Western Society of Allergy, Asthma & Immunology (WSAAI)
Jan. 22-26, 2006
Lanai City, Hawaii
Tel: 623-266-9148
Fax: 628-266-7885
Link
ONGOING
World Allergy Organization Society Meetings
|
Sponsored
By |
 |
|
|
|
|
|
|
|
|
| |
Top
Stories |
| |
Study: Minorities willing to participate in
research
Minorities participate in health research studies at the
same rate as non-Hispanic whites when they are made aware of the
study and meet the medical requirements, according to a report
in PLoS Medicine, published by the Public Library of
Science. The findings dispute the common belief that minorities
are less willing to participate. Researchers at the National
Institutes of Health identified and reviewed 20 studies that
involved more than 70,000 patients over 20 years in a variety of
types of research studies. Researchers found only small
differences in the willingness of minorities to participate, but
big differences in who was asked to participate.

Vitamin D may help steroid-resistant patients
Vitamin D can improve responsiveness among patients who fail
to respond to steroids, according to a study in the Journal
of Clinical Investigation. The study’s results suggest that
steroid treatment works, at least in part, by inducing the
T-cells of the immune system to synthesize a secreted signaling
molecule, IL-10, which inhibits the immune responses that cause
allergic and asthmatic disease symptoms. T-cells from
steroid-resistant patients did not produce IL-10 when cultured
in vitro with the steroid, dexamethasone. But when vitamin D3
was added to the culture medium along with dexamethasone, this
was reversed. Researchers gave patients with asthma, who were
unresponsive to steroids, daily vitamin D3 supplements for seven
days. Blood tests showed the patients' T-cells were more
responsive to dexamethasone after they had taken the
supplements.
FDA publishes food allergen labeling information
The Food and Drug Administration recently published
information on its Web site for food manufacturers and
consumers about the Food Allergen Labeling and Consumer
Protection Act of 2004 (FALCPA), including a revision relating
to the status of food allergen cross contact residues. The
site includes questions and answers about food allergens in
general and FALCPA specifically.
Treating allergic rhinitis may be key to asthma control
Asthma management requires suitable treatment of allergic
rhinitis, according to a study in Chest. Scientists at
University of Sao Paulo School of Medicine in Brazil evaluated
the effects of treatment with inhaled or topical nasal steroid
beclomethasone dipropionate, given separately or in
combination to 74 patients with mild-to-moderate asthma and
allergic rhinitis. Patients in all treatment groups showed
significant improvements in lung function, as well as in
emergency department visits, nighttime waking due to asthma,
and asthma-related work absences.
U.S. customs agents confiscate counterfeit Tamiflu
Customs agents near San Francisco recently intercepted more
than 50 shipments of counterfeit Tamiflu, the antiviral drug
being stockpiled in case of a bird flu pandemic—the first
such seizure in the United States, according to authorities.
The counterfeits included none of Tamiflu's active
ingredients. Initial tests indicate some vitamin C in the
capsules, according to an FDA spokesperson. So far,
intercepted shipments were bound only for individuals who
placed Internet orders. None were bound for doctors or
hospitals.
|
| |
|
|
|
A
word from Dr. William Dolen, president
Let’s continue exploring options for the funding of
allergy-immunology training programs. (Again, please
send an e-mail to the ACAAI office with your
feedback.) We pick up from the last issue at No. 4.
4. Private donations for a particular fellow.
An allergy practice or an individual agrees to make a
donation that covers expenses for a two-year
allergy-immunology fellowship. The institution pays
the fellow from the donation, at a salary equivalent
to other institutional PGY-4 and PGY-5 salaries.
Advantages
The fellow is paid at the same rate as peers in other
subspecialty fellowships.
Disadvantages
Some sort of agreement needs to ensure that the entire
grant is received or otherwise guaranteed before the
fellow signs an institutional training contract.
Otherwise, if funds are withdrawn for some reason, the
institution might be obligated to provide funding for
the remainder of the fellowship.
When the donor is an allergy practice group, it is
likely that the fellow would be contractually
obligated to join that practice after training, and
repay the cost of training over a period of time. If,
in the course of training, the fellow decides not to
join that practice, there could be issues. This
potential event would have to be addressed
prospectively in any agreement between the fellow and
the allergy practice, as well as the fellow’s contract
with the institution.
A fellow candidate with this kind of funding would
have an unfair advantage over a more highly qualified
candidate without funding.
5. Funding by the national allergy-immunology
organizations. Both the ACAAI (Acorn grants, the ACAAI
Foundation) and the AAAAI (ERT) have foundations and
other sources of funds for fellowship training.
Advantages
Current availability
Disadvantages
Very limited funds are available for a large number of
applicants.
6. The federal government. This was once the
major source for subspecialty funding, which was
reduced by the Balanced Budget Act. The JCAAI is
actively designing an analysis of political options to
restore funding for the cognitive outpatient-based
specialties. The ACAAI and JCAAI hope to lobby
Congress in 2006.
7. The last option is that the medical schools
and their associated hospitals should fund
allergy-immunology fellowship training. Most of those
responding to the recent poll believe that this is the
most appropriate source for funding. One individual
wrote that having local control is preferable to
federal control over how training might be conducted.
Another person wrote that money earned by fellows
working in the clinics and the hospital benefits the
medical school and the hospital, and ought to go to
cover the salaries of staff and fellows. Do any of the
medical schools and/or hospitals have a practice plan
in which clinical income covers salaries for staff and
fellows? If so, please send a description to the ACAAI
office.
Dr. William Dolen
ACAAI president |
|
|
|
Plan to attend the ACAAI-HSACI meeting in Greece
The ACAAI and Hellenic Society of Allergy & Clinical
Immunology (HSACI) are co-sponsoring a
Joint Allergy Symposium, Allergy Update in
Greece, Sept. 6-9, 2006, in beautiful Athens.
This international meeting brings together many of the
finest researchers and clinicians to present cutting-edge
lectures on the most important topics for the clinical
practice of allergy and immunology.
Plan to join your colleagues in Athens, one of the most
exciting cities in the world, the metropolis of wisdom,
philosophy and inspiration. The modern Athens Ledra
Marriott Hotel is the perfect venue for this meeting, with
its spacious conference center and view of the Acropolis.
|
|
|
|
Drugs
and Devices |
|
|
Xopenex HFA metered-dose
inhaler now available
Sepracor Inc. recently
announced that Xopenex HFA (levalbuterol tartrate) Inhalation
Aerosol, a hydrofluoroalkane metered-dose inhaler, is now
available by prescription. Xopenex HFA is a short-acting
beta-agonist for the treatment or prevention of bronchospasm
in patients four years and older with reversible obstructive
airway disease.
 |
|
|
Association
News |
| |
|
Take advantage
of $100 ACAAI member discount for iHealth Services
As an ACAAI member, you have access to a practice Web site
that has recently been upgraded with tools that can help you
increase your practice revenue, improve patient satisfaction,
reduce your liability and improve your practice marketing.
Beginning in 2006, ACAAI members will be able to continue
utilizing iHealth Services for just $17 per month—a $100
annual savings because the College is a founding member of
Medem. If you have 300 of your patients sign up for an
iHealthRecord via your practice Web site in 2006 or
perform at least one charged-for Online Consultation on
average per week during the 2006 calendar year, your 2006 fees
will be credited to your 2007 subscription.
By using Medem, Inc.’s iHealth Services you can create a
practice Web site, have your patients complete a
secure online personal health record—the iHealthRecord—communicate
with them through Online Consultation and Secure
Messaging tools to provide your patients with health education
and adherence programs, including asthma and other allergic
diseases. If you have any questions contact Medem’s Member
Services at info@medem.com
or 877-926-3336.
The AAAAI/ACAAI Certification/Maintenance
of Certification Board Review Course to be April 6-9
The 2006 AAAAI/ACAAI Certification/Maintenance of
Certification Board Review Course is April 6-9 at the Westin
Michigan Avenue Hotel in Chicago. The intensive literature
review course will give you the winning edge whether you are
preparing for the ABAI exam, ABAI recertification, or simply
strengthening your skills. The program and registration are
online.
Developed by outstanding faculty members, this three and
one-half day course covers the major concepts included in the
written exam and includes a comprehensive syllabus.
Participants will hear summaries and review questions on
subjects of interest to allergist/immunologists. At the
conclusion of the meeting, participants should be able to
identify, evaluate and manage the current problems and issues
in allergy/immunology in preparation for the ABAI examination.
ABAI Certification, Recertification Exams Oct. 9-13, 2006
Due to conflicts at the computer-based testing centers, the
ABAI will administer both the Certification and
Recertification Examinations the week of October 9-13, 2006.
For more information, please contact the ABAI:
American Board of Allergy and Immunology
510 Walnut Street, Suite 1701
Philadelphia, PA 19106-3699
Tel 215-592-9466; Fax 215-592-9411
http://www.abai.org
abai@abai.org
Allergy Practice Tip: Get
Smiles
Advice from The Patient-Centered Allergy Practice
Friendly employees beget happy patients. Consider hiring
front-end staff based on personality as much as experience.
And hard-working quick learners with good customer service
skills are a must. For more advice, visit
www.PatientCenteredAllergyPractice.com.
These tips are drawn The Patient-Centered Allergy Practice,
a CME Series in Practice Management, supported through an
educational grant from sanofi-aventis Group and
endorsed by the American College of Allergy, Asthma &
Immunology. |
|
|
Fellows-in-Training |
| |
|
Immunology Review Corner
Welcome to the Board Review Corner, prepared by Dr. Karla R.
Davis, senior representative of ACAAI’s fellows-in-training (FITs)
to the Board of Regents. The Board Review Corner is your chance
to test your Board preparedness.
To refer to a previous Board Review Corner, click the “Archive”
link in the left column.
Immunology Review Corner: Chapter 59, Part II of the 6th edition
of Middleton’s Allergy Principles and Practice, edited by
N. Franklin Adkinson, et al. Review questions were written by
Drs. Thao Tran and Karla Davis.
 |
|
|
Copyright
© 2005 American College of Allergy, Asthma & Immunology. All
rights reserved.
E-newsletter services provided by the medical editors at Ascend
Media, LLC.
Do you have news, responses or opinions to share with us? Please
e-mail the association office at
enews@acaai.org.
THIS E-MAIL WAS SENT FROM A “SEND-ONLY” MAILBOX. Please DO NOT REPLY
to this e-mail. |
|
ACAAI eNews is sent as a membership benefit of the American
College of Allergy, Asthma & Immunology. If you would prefer not
to receive future issues and want to remove your name from our
mailing list, please
-click here- |
|
|
|
|
|
|
|
|